Almonds and pecans: the cholesterol number belongs to almonds

Almonds carry the stronger half of this pair. Pooling 48 almond-control datasets from 36 publications in 2485 adults without cardiovascular disease, in trials lasting at least four weeks, almonds lowered LDL cholesterol by 5.1 mg/dL (0.132 mmol/L), with a confidence interval running from 2.9 to 7.3 mg/dL (0.075 to 0.190 mmol/L) of reduction, and total cholesterol by 6.2 mg/dL (0.160 mmol/L). The comparison was a diet with no nuts in it rather than an equal-calorie swap, so part of that gap is the almonds arriving and part is whatever they displaced. Pecans have nothing of that size behind them. What we found on pecans is a single-meal crossover in 16 healthy adults aged 23 to 44, where plasma gamma-tocopherol doubled eight hours after one pecan meal, which is an acute postprandial response and not a measure of what weeks of eating do. In people who already have atherosclerotic cardiovascular disease the picture flattens out. Five randomized trials of 6 to 12 weeks in 439 patients, feeding almonds, pecans, Brazil nuts or mixed nuts, moved only the atherogenic index, by 0.32 units, and left the other lipid and inflammatory markers where they were. Blood pressure did not shift: systolic changed by 1.16 mmHg with a confidence interval from -5.68 to 3.35, which crosses zero. The EU register holds zero authorized claims for almonds. It refused both the handful-a-day cholesterol claim and the wider claim that 1.1 oz (30 g) of nuts a day helps maintain heart health, a line that names almonds and pecans outright. Non-authorized means the evidence did not satisfy the assessors at the time, not that the effect was ruled out.

How much is actually in it

• Almond and pecan are covered together in a systematic review of tree nut lipid components and phytochemicals: polar lipids, squalene, phytosterols, tocochromanols and polyphenols. — groundnut and common tree nuts including almond and pecan, chemical profiling literature Evidence D source
  Composition described qualitatively: unsaturated fatty acids plus polar lipids, squalene, phytosterols, tocochromanols and polyphenolic compounds

What a real portion looks like

• Trials of nuts including almonds and pecans used 5 g to 85 g a day, with a median of 1.1 oz (30 g) a day for 6 to 12 weeks. — five randomized clinical trials in patients with atherosclerotic cardiovascular disease (n = 436) Evidence A source
  Portion range 5 g to 85 g per day, median 30 g per day; intervention 6 to 12 weeks

What your body absorbs

• Pecan constituents are absorbed: plasma gamma-tocopherol doubled 8 hours after a single pecan meal in 16 healthy adults. — 16 healthy men and women aged 23 to 44 years, BMI 22.7, crossover with 1-week washout, single test meals (n = 16) Evidence B source
  Gamma-tocopherol doubled at 8 h (P < 0.001); hydrophilic and lipophilic ORAC up 12 and 10 percent at 2 h
• Not all the fat in almonds is absorbed: measured metabolizable energy of raw almonds was 18.5 kJ/g, below the Atwater prediction. — adults aged 18 years and older in human feeding studies plus in vitro digestion models, 21 studies (n = 21 studies) Evidence C source
  Metabolizable energy 18.5 kJ/g for raw almonds and 22.6 kJ/g for pistachios, consistently below Atwater factors

What cooking and storage change

• Grinding and roasting raise how much energy you get from nuts: metabolizable energy rose in the order whole, chopped, flour and raw, roasted, butter. — adults aged 18 years and older in human feeding studies plus in vitro digestion models, 21 studies (n = 21 studies) Evidence C source
  Metabolizable energy higher for flour than chopped than whole nuts, and higher for butter than roasted than raw; 22.6 kJ/g pistachios versus 18.5 kJ/g raw almonds
• Aflatoxin B1 contamination is the named safety issue for tree nuts, and physical decontamination removed 70 to 95 percent of it while inducing lipid oxidation in treated matrices such as pistachios. — 41 original studies on tree nut batches, 2005 to 2025, laboratory and industrial processing (n = 41 studies) Evidence D source
  Cold atmospheric plasma and UV-C reduced aflatoxin by 70 to 95 percent; lipid oxidation increased, and ozonation or organic acids cost up to 29 percent of alpha-tocopherol in hazelnuts

What it does to your health

• Almond consumption lowered LDL cholesterol by 5.1 mg/dL (0.132 mmol/L) in adults without cardiovascular disease across trials of at least 4 weeks. — adults without cardiovascular disease, 48 almond-control datasets from 36 publications, trials at least 4 weeks long (n = 2485) Evidence A source
  LDL-C -5.1 mg/dL (95% CI -7.3 to -2.9; metric: -0.132 mmol/L, -0.190 to -0.075); TC -0.160 mmol/L (95% CI -0.218 to -0.101); ApoB -4.552 mg/dL (95% CI -6.460 to -2.645)
• In people who already have atherosclerotic cardiovascular disease, 6 to 12 weeks of nuts including almonds and pecans changed only the atherogenic index, by 0.32 units. — adults with atherosclerotic cardiovascular disease, five randomized clinical trials, 6 to 12 weeks (n = 439) Evidence A source
  Atherogenic index MD -0.32 (95% CI -0.58 to -0.06), I2 = 0%, moderate certainty; no significant effect on other lipid or inflammatory biomarkers
• Nuts including almonds and pecans did not lower blood pressure in secondary cardiovascular prevention: systolic change was 1.16 mmHg with a confidence interval crossing zero. — patients with atherosclerotic cardiovascular disease, five randomized clinical trials, 6 to 12 weeks (n = 436) Evidence A source
  Systolic MD -1.16 mmHg (95% CI -5.68 to 3.35), I2 = 0%, moderate certainty; diastolic MD 0.10 mmHg (95% CI -2.30 to 2.51), high certainty

Safety, limits and interactions

• Almonds are among the food matrices most often studied for aflatoxin decontamination in tree nuts. — 41 studies included in a scoping review of aflatoxin decontamination in tree nuts (n = 41 studies) Evidence D source
  Almonds listed first among the most frequently assessed matrices, alongside pistachios, Brazil nuts, hazelnuts and walnuts
• Five handfuls of almonds a day, eaten with chia seeds, preceded biopsy-confirmed oxalate nephropathy in one 59-year-old woman. — one 59-year-old woman with controlled hypertension, on a self-chosen high-oxalate diet for irritable bowel syndrome (n = 1) Evidence D source
  Creatinine rose from 1.3 to 1.8 mg/dL; renal biopsy showed calcium oxalate deposition; markers improved on a low-oxalate diet

What people believe that the data does not support

• The EU refused the right to say that a handful of almonds a day helps maintain healthy blood cholesterol and promotes a healthy heart. — EU Register on nutrition and health claims, snapshot 2026-09-21, claim POL-HC-6583 Evidence E source
  Status Non-authorized; zero authorized claims for almonds in the register
• The EU also refused the wider claim that 1.1 oz (30 g) of nuts a day, almonds and pecans named explicitly, helps maintain heart health. — EU Register on nutrition and health claims, snapshot 2026-09-21, claim POL-HC-7666 Evidence E source
  Status Non-authorized; the substance line names almonds and pecans explicitly

Who this works differently for

• Three children developed hyperoxaluria with hematuria, dysuria or kidney stones after heavy almond milk intake, and all resolved when it stopped. — 3 children drinking excessive amounts of almond milk products (n = 3) Evidence D source
  All genitourinary and urinary metabolic disturbances resolved after discontinuation; almond milk products measured as a particularly rich source of dietary oxalate
• For people with chronic kidney disease the whole evidence base on nuts is four studies, and all four carry a moderate-to-high risk of bias. — patients with chronic kidney disease, four studies (three trials, one cohort) (n = 1270) Evidence C source
  Walnuts lowered LDL cholesterol and blood pressure without disturbing electrolytes; total nut intake associated with lower all-cause mortality

What is still unknown

• Authors of the kidney-disease review state that their findings cannot yet be translated into practice and that further studies are required. — patients with chronic kidney disease, four studies (n = 1270) Evidence C source
  No practice recommendation issued; evidence judged insufficient

The bottom line

A portion here is 30 g. That is the median dose across those five trials, which fed between 5 g and 85 g a day for 6 to 12 weeks, and it describes what researchers handed out rather than what anyone eats at home, because we have no national intake figure for this pair. You also absorb less than the label predicts. A systematic review of 21 human feeding and laboratory digestion studies, narrative rather than a synthesis of randomized trials, measured raw almonds at 18.5 kJ/g, consistently below the Atwater factors, with the unreleased fat leaving in stool. The same review found that form changes the figure, energy availability rising from whole to chopped to flour and from raw to roasted to nut butter. That is a direction, not a number for each step, and pecans were not among the nut types measured. Two kidney signals sit in the caution column and both are single reports. A 59-year-old woman eating five handfuls of almonds and six tablespoons of chia seeds a day for irritable bowel symptoms had creatinine rise from 1.3 to 1.8 mg/dL, with calcium oxalate found on biopsy. It is one case, and the chia cannot be separated from the almonds in it. Three children drinking large amounts of almond milk developed hyperoxaluria with hematuria, dysuria or stones, and everything resolved when the drink stopped. Those three cases are about a beverage measured as unusually high in oxalate, not about whole nuts. If you have chronic kidney disease, the entire nut literature for you is four studies in 1270 people, all at moderate-to-high risk of bias. None of the four tested almonds or pecans on their own, and the authors say their findings cannot be translated into practice yet. Aflatoxin B1 is the contamination named for tree nuts, and almonds are among the matrices most often studied for it, which reflects where researchers look rather than how often a bag on the shelf is contaminated. The decontamination work is done on batches in laboratories and factories, and it has no version you can perform in a kitchen. Nothing we found speaks to tree nut allergy, and almonds and pecans are tree nuts. There is no USDA composition entry for this pair, so this page has no per-100 g table. The one composition source we found treats almond and pecan qualitatively, listing unsaturated fatty acids alongside polar lipids, squalene, phytosterols, tocochromanols and polyphenols, with no amounts attached to any of them.

Sources

1. alpe-daily-r1-16 · systematic review, composition
   This contribution analyses the general chemical profile of groundnut and common tree nuts (almond, walnut, cashew, hazelnut, pistachio, macadamia, pecan), focusing on lipid components and phytochemicals, with a view on their bioactive properties.
   Crit Rev Food Sci Nutr, 2024 · checked 2026-09-25
2. alpe-daily-r1-04 · meta-analysis of RCTs
   The nuts evaluated were almonds, pecans, Brazil nuts, and mixed nuts, with portions that varied between 5 g and 85 g (median: 30 g/day). The intervention period varied between 6 and 12 weeks.
   Nutr Rev, 2025 · checked 2026-09-25
3. alpe-daily-r1-05 · randomized crossover RCT
   Sixteen healthy men and women (23-44 y, BMI 22.7 ± 3.4) were randomly assigned to 3 sequences of test meals composed of whole pecans, blended pecans, or an isocaloric meal of equivalent macronutrient composition but formulated of refined ingredients in a crossover design with a 1-wk washout period between treatments. ... Following the whole and blended pecan test meals, plasma concentrations of γ-tocopherols doubled at 8 h (P < 0.001) and hydrophilic- and lipophilic-ORAC increased 12 and 10% at 2 h, respectively.
   J Nutr, 2011 · checked 2026-09-25
4. alpe-daily-r1-06 · systematic review, narrative synthesis
   The ME of nuts was consistently lower than that predicted by Atwater factors for investigated nut types (almonds, cashews, hazelnuts, pistachios, walnuts, and peanuts). The mechanisms may relate to a lower fat release from nuts, hence higher fecal fat excretion
   Adv Nutr, 2023 · checked 2026-09-25
5. alpe-daily-r1-07 · systematic review, narrative synthesis
   ME was influenced by nut type (ME = 22.6 kJ/g for pistachios; ME = 18.5 kJ/g for raw almonds), physical form (flour > chopped > whole nuts), heat processing (butter > roasted > raw) and dose of consumption.
   Adv Nutr, 2023 · checked 2026-09-25
6. alpe-daily-r1-08 · scoping review
   Physical approaches, particularly cold atmospheric plasma and UV-C radiation, achieved robust reduction rates ranging from 70% to 95%; however, these highly energetic treatments often induced lipid oxidation, evidenced by linear increases in malondialdehyde (MDA) levels in matrices such as pistachios.
   Mycotoxin Res, 2026 · checked 2026-09-25
7. alpe-daily-r1-01 · meta-analysis of RCTs
   36 publications (48 almond-control datasets) representing 2485 participants were included. Almond consumption significantly reduced LDL-C (-0.132 mmol/L; 95% CI: -0.190, -0.075 mmol/L; p < 0.001), TC (-0.160 mmol/L; 95% CI: -0.218, -0.101 mmol/L; p < 0.001), non-HDL-C (-0.204 mmol/L; 95% CI: -0.281, -0.127 mmol/L; p < 0.001)
   Nutrients, 2025 · checked 2026-09-25
8. alpe-daily-r1-02 · meta-analysis of RCTs
   Compared to nut-free diets, nut intake did not have a statistically significant effect on lipid profile biomarkers, except on the atherogenic index (MD: -0.32 [95% CI -0.58 to -0.06], I2 = 0% - moderate certainty of the evidence). Similarly, there was no effect of nuts on inflammatory profile biomarkers.
   Eur J Nutr, 2024 · checked 2026-09-25
9. alpe-daily-r1-03 · meta-analysis of RCTs
   They also had no effect on systolic (mean difference [MD]: -1.16 mmHg [95% CI, -5.68 to 3.35], I2 = 0%-moderate certainty of evidence) or diastolic (MD: 0.10 mmHg [95% CI, -2.30 to 2.51], I2 = 0%-high certainty of evidence) blood pressure.
   Nutr Rev, 2025 · checked 2026-09-25
10. alpe-daily-r1-09 · scoping review
    The studies included in this scoping review examined various methods for decontaminating or reducing AFs in tree nuts, with most publications appearing between 2005 and 2025, reflecting increasing scientific interest in food safety and mycotoxin control. The most frequently assessed food matrices were almonds, pistachios, Brazil nuts, hazelnuts, and walnuts, although some studies included other varieties.
    Mycotoxin Res, 2026 · checked 2026-09-25
11. alpe-daily-r1-10 · case report
    A 59-year-old woman with a history of controlled hypertension presented with creatinine 1.8 mg/dL, increased from baseline 1.3 mg/dL. ... Diet included six tablespoons of chia seeds and five handfuls of almonds daily to manage IBS symptoms. ... Renal biopsy showed glomerulosclerosis, fibrosis and calcium oxalate deposition.
    BMJ Case Rep, 2020 · checked 2026-09-25
12. alpe-daily-r1-12 · regulatory decision
    POL-HC-6583 Almonds Consuming a handful (28 grams) of almonds a day as part of a diet low in saturated fat, helps to maintain healthy blood cholesterol and promotes a healthy heart Non-authorised
    EU Register on nutrition and health claims, claim POL-HC-6583, snapshot 2026-09-21 · checked 2026-09-25
13. alpe-daily-r1-13 · regulatory decision
    POL-HC-7666 Nuts - peanuts and tree nuts (almonds, hazelnuts, pecans, pistachios and walnuts), excluding brazil, macadamia and cashew nuts Eating 30g of nuts per day as part of a balanced diet helps maintain heart health. Non-authorised
    EU Register on nutrition and health claims, claim POL-HC-7666, snapshot 2026-09-21 · checked 2026-09-25
14. alpe-daily-r1-11 · case series
    We describe 3 children presenting with hematuria, dysuria or kidney stones, and hyperoxaluria believed to be related to ingestion of excessive amounts of almond milk products. Our investigation of the oxalate content of several popular plant-based milk substitutes indicates that almond milk products are a particularly rich source of dietary oxalate.
    J Pediatr, 2015 · checked 2026-09-25
15. alpe-daily-r1-14 · systematic review
    The search identified 2,521 records, with four studies (three trials, one cohort) involving 1,270 CKD patients meeting the inclusion criteria. The studies were heterogeneous in terms of intervention and biomarkers assessed, and all of them had moderate-to-high risk of bias.
    Front Nutr, 2025 · checked 2026-09-25
16. alpe-daily-r1-15 · systematic review
    Our review indicates potential benefits for the inclusion of nuts in the diet of patients with CKD, but further studies are required to translate findings into practice.
    Front Nutr, 2025 · checked 2026-09-25